About the CTU

Group discussing CTU Untitled Page

Anglia Ruskin Clinical Trials Unit (ARCTU) is a research partnership between Anglia Ruskin Universities' Postgraduate Medical Institute, NHS Trusts from Cambridgeshire, Essex and Hertfordshire, and industry partners. 

Together, our NHS Trusts cover a local patient population of over 3 million. In addition, our two tertiary centres; The Essex Cardiothoracic Centre and St Andrews Centre for Plastic Surgery and Burns, takes this population to over 10 million.

Our aim is to work with hospital trusts, healthcare providers, commissioners and commercial companies to increase opportunities for patients to take part in both investigator led and commercial trials.

For our investigator led trials we aim to support investigators through each step of the clinical trial lifecycle. We offer investigators the support to take their study from a basic idea and develop it into a well-designed study. An investigator can be anyone working in a clinical environment (e.g. doctors, nurses and allied health professionals).

We also work with SMEs (small to medium-sized enterprises) and larger commercial companies who are looking to test their products in a clinical environment. The support we offer ranges from providing advice on the regulatory environment in the UK, to helping to plan and run large scale studies.

Alongside the investigator initiated work, we also have a partnership with Quintiles, the world's largest Contract Research Organisation. This work supports the delivery of studies from the Quintiles pipeline at our local partner trusts.

Read more about our current studies.

Research papers

Title  Automated Quantification of Stroke Damage on Brain Computer Tomography Scans: e-ASPECTS 
Authors  James Hampton-Till, Michael Harrison, Anna Luisa Kühn, Oliver Anderson, Devesh Sinha, Sharon Tysoe, Eric Greveson, Michalis Papadakis, Iris Q. Grunwald 

European Medical Journal (EMJ) – Neurology
Title  Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial 
Authors  Sreekanth Palvai, Michael Harrison, Sharon Shibu Thomas, Karen Hayden, James Green, Oliver Anderson, Lavinia Romero, Richard Lodge, Patricia Burns, Imtiaz Ahmed 
Journal  JMIR Research Protocols
Link http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430680/

Key members of staff

CTU Director

Karen Hayden, Trials Data Manager

Arit Udoh, Clinical Trials Coordinator

Laura Giles, Clinical Trials Unit Administrator

Tomer Regev, Project Manager

Jufen Zhang, Trials Statistician

Contact details

Please email: arctu@anglia.ac.uk

Anglia Ruskin Clinical Trials Unit
Post Graduate Medical Institute
Anglia Ruskin University
Bishops Hall Lane
Chelmsford, CM1 1SQ
Fax: 01245 684437
Tel: 01245 684630